Dr Kevin Schulman joins Ethics Talk to discuss his article, coauthored with Dr Barak Richman: “Informed Consent as a Means of Acknowledging and Avoiding Financial Toxicity as Iatrogenic Harm.”

Dr Harold A. Pollack joins Ethics Talk to discuss his article: “Necessity for and Limitations of Price Transparency in American Health Care.”

Dr Sherry Glied joins Ethics Talk to discuss her article, coauthored with Grace Kim: “Which Price Should Be Transparent and Why?”

Sarosh Nagar joins Ethics Talk to discuss his article, coauthored with Drs Leah Z. Rand and Aaron S. Kesselheim: “What Should US Policymakers Learn From International Drug Pricing Transparency Strategies?”

Dr Nisha M. Patel joins Ethics Talk to discuss her article, coauthored with Drs Jesse M. Ehrenfeld and Brian J. Miller: “What Should ‘Shopping’ Look Like in Actual Practice?”

Professor Michael R. Ulrich joins Ethics Talk to discuss his article: “Why Money Is Well Spent on Time.”

Jamaljé R. Bassue joins Ethics Talk to discuss his short film: “You Might Be Here Awhile.”

For dying patients and their loved ones to make informed decisions, physicians must share adequate information about prognoses, prospective benefits and harms of specific interventions, and costs.

Fragmentation in US health care delivery streams and shortcomings in formal quality measures mean that transparency could be more useful to policymakers and regulators than patients.

This article analyzes differences in prescription drug pricing transparency practices among 3 Organisation of Economic Co-operation and Development member nations.